WEIIF yields 1416.53% · JNJ yields 2.14%● Live data
📍 WEIIF pulled ahead of the other in Year 1
Combined, WEIIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WEIIF + JNJ for your $10,000?
Wolverine Energy and Infrastructure Inc., through its subsidiaries, provides energy and infrastructure services to the conventional and renewable energy sectors in Western Canada and the United States. The company is involved in the rental and sale of tubular and oilfield equipment, including combination units; recycle units, portable sewage containments, and gang washrooms; 400 barrel tanks; boilers and heat exchangers; matting equipment; well site accommodations and portable office trailers; lease equipment; safe work platforms; flare stacks; flowline/manifolds; flare knock-out drums; line heaters; and pressurized storage equipment. It also provides trailer rental, production testing, and sand management services. In addition, the company undertakes earthworks contractor and excavating works, including water and sewer, site excavation, utilities service and maintenance, horizontal directional drilling, underground gas line installation, polyethylene fusion, and snow management projects; and offers seismic services, such as mulching, slashing, dozer, and QST services. Further, it offers water transfer, management, and heating services. The company was founded in 1952 and is headquartered in Nisku, Canada.
Full WEIIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.